Target nature :
CAS n° :
Mecanism of action :
Inhibition of CK2 kinase inhibition
Physico-chemical properties :
Molecular weight 282.72 g.mol-1
Probe availability :
Chimiothèque Institut Curie-CNRS
Princeps reference :
Cancer Research (2010), 70(23), 9865 DOI: 10.1158/0008-5472.CAN-10-0917
More bibliography :
Bioconjugate Chem. 2003, 14, 120 doi10.1021/bc020038w
Other available information on the probe :
Other information on the target :
Selectivity profile :
Panel of 57 recombinant protein kinases.
Kinase selectivity profiling of Pyridocarbazole CK2-compound 18 showed that several kinases were significantly affected : Pim-1, Mnk2, DRAK1.
In vivo data :
The compound inhibits colony formation and tumor growth.
3 times a week during two weeks (intraperitoneal injection in xenografted tumors (U373 cells) in harlan athymic nude mice.
0.14 mg/100 µL per injection dissolved in PEG3350 22.5%, bovine serum albumin 0.45%
In vitro data :
IC50 (CK2) = 1.5 µM
No in vivo toxicity reported during the in vivo study.
Contact the author of the biotool
Chaine SMILES :